Impact of Variations in Urinary pH on the Pharmacokinetics of LY2140023 and LY404039 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 11 Oct 2011
At a glance
- Drugs Pomaglumetad methionil (Primary)
- Indications Psychotic disorders
- Focus Pharmacokinetics
- 11 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2011 New trial record